CT45A1 and neoplasm: However, CT45A1, a highly expressed tumor antigen with a relatively low FDR among the other differentially expressed (DE) genes in the aggressive MSI‐H CRC tumors (Fig. 1B and Table S4), was not annotated in the functional enrichment analysis (Fig. 1C).